Greenwich Lifesciences (GLSI.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov15

Greenwich Lifesciences released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.8527

04:00

Greenwich Lifesciences released FY2025 Q3 earnings on November 14, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -0.3043 (forecast USD -0.36)

04:00

Oct9

Greenwich Life Sciences Assessing Preventative Breast Cancer Immunotherapy GLSI-100

10:37

Aug15

Greenwich Lifesciences released FY2025 Semi-Annual earnings on August 14, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.5488

03:00

Greenwich Lifesciences released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.301 (forecast USD -0.24)

03:00

Jun27

Greenwich LifeSciences Announces Global Expansion of GLSI-100 Breast Cancer Vaccine Phase III Clinical Trial

13:00